The immunologic role of IL-23 in psoriatic arthritis: a potential therapeutic target.

导出 LinkOut

翻译打印收藏纠错

第一作者： Qin-Yi,Su

第一单位： Department of Rheumatology, The Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.;Shanxi Provincial Key Laboratory of Rheumatism Immune Microecology, Taiyuan, Shanxi, China.;Ministry of Education, Key Laboratory of Cellular Physiology at Shanxi Medical University, Taiyuan, China.

作者： Qin-Yi,Su ^[1] ; Heng-Yan,Gao ^[2] ; Yue-Ru,Duan ^[2] ; Jing,Luo ^[2] ; Wei-Ze,Wang ^[2] ; Xi-Chao,Qiao ^[2] ; Sheng-Xiao,Zhang ^[3]

作者单位： Department of Rheumatology, The Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.;Shanxi Provincial Key Laboratory of Rheumatism Immune Microecology, Taiyuan, Shanxi, China.;Ministry of Education, Key Laboratory of Cellular Physiology at Shanxi Medical University, Taiyuan, China. ^[1] Shanxi Provincial Key Laboratory of Rheumatism Immune Microecology, Taiyuan, Shanxi, China.;Ministry of Education, Key Laboratory of Cellular Physiology at Shanxi Medical University, Taiyuan, China. ^[2] Department of Rheumatology, The Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.;Shanxi Provincial Key Laboratory of Rheumatism Immune Microecology, Taiyuan, Shanxi, China.;Ministry of Education, Key Laboratory of Cellular Physiology at Shanxi Medical University, Taiyuan, China.;SXMU-Tsinghua Collaborative Innovation Center for Frontier Medicine, Shanxi medical university, Taiyuan, China. ^[3]

关键词 IL-23 IL-23 inhibitors IL-23R psoriatic arthritis therapeutic target

主题词人类(Humans);关节炎, 牛皮癣(Arthritis, Psoriatic);白细胞介素23(Interleukin-23);动物(Animals);分子靶向治疗(Molecular Targeted Therapy);抗体, 单克隆(Antibodies, Monoclonal)

DOI 10.1080/14712598.2024.2401148

PMID 39230202

发布时间 2024-10-25

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交